GC
CCRN icon

Guggenheim Capital’s Cross Country Healthcare CCRN Stock Holding History

Guggenheim Capital’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,146
Closed -$258K – 1765
2025
Q3 		$258K Sell
18,146
-2,897
-14% -$38.3K ﹤0.01% 1438
2025
Q2 		$275K Buy
21,043
+9,978
+90% +$137K ﹤0.01% 1416
2025
Q1 		$165K Hold
11,065
– – ﹤0.01% 1559
2024
Q4 		$201K Buy
+11,065
New +$149K ﹤0.01% 1600
2024
Q2 		– Sell
-11,284
Closed -$211K – 1871
2024
Q1 		$211K Sell
11,284
-9,381
-45% -$188K ﹤0.01% 1778
2023
Q4 		$468K Buy
+20,665
New +$448K ﹤0.01% 1479
2023
Q1 		– Sell
-11,499
Closed -$306K – 1930
2022
Q4 		$306K Buy
+11,499
New +$375K ﹤0.01% 1666
2022
Q3 		– Sell
-15,208
Closed -$317K – 1924
2022
Q2 		$317K Buy
+15,208
New +$285K ﹤0.01% 1756
2022
Q1 		– Sell
-7,916
Closed -$220K – 2131
2021
Q4 		$220K Sell
7,916
-7,364
-48% -$179K ﹤0.01% 2002
2021
Q3 		$325K Sell
15,280
-26,797
-64% -$503K ﹤0.01% 1893
2021
Q2 		$695K Buy
42,077
+16,916
+67% +$258K ﹤0.01% 1673
2021
Q1 		$314K Buy
+25,161
New +$267K ﹤0.01% 1933
2019
Q4 		– Sell
-41,339
Closed -$426K – 2080
2019
Q3 		$426K Buy
41,339
+28,009
+210% +$276K ﹤0.01% 1690
2019
Q2 		$125K Sell
13,330
-5,323
-29% -$41K ﹤0.01% 2060
2019
Q1 		$131K Buy
18,653
+4,034
+28% +$34.6K ﹤0.01% 2127
2018
Q4 		$107K Buy
14,619
+3,740
+34% +$31.3K ﹤0.01% 2123
2018
Q3 		$95K Buy
+10,879
New +$111K ﹤0.01% 2377
2018
Q2 		– Sell
-57,824
Closed -$641K – 2405
2018
Q1 		$641K Sell
57,824
-8,337
-13% -$104K ﹤0.01% 2277
2017
Q4 		$844K Sell
66,161
-55,829
-46% -$738K ﹤0.01% 2161
2017
Q3 		$1.74M Buy
121,990
+10,060
+9% +$126K ﹤0.01% 1770
2017
Q2 		$1.44M Sell
111,930
-12,663
-10% -$163K ﹤0.01% 1851
2017
Q1 		$1.79M Sell
124,593
-18,698
-13% -$275K ﹤0.01% 1747
2016
Q4 		$2.24M Sell
143,291
-11,264
-7% -$154K 0.01% 1585
2016
Q3 		$1.82M Sell
154,555
-16,867
-10% -$222K 0.01% 1691
2016
Q2 		$2.39M Sell
171,422
-12,361
-7% -$164K 0.01% 1453
2016
Q1 		$2.14M Sell
183,783
-33,255
-15% -$423K 0.01% 1527
2015
Q4 		$3.56M Buy
+217,038
New +$3.45M 0.01% 1211
2015
Q3 		– Sell
-10,879
Closed -$138K – 2965
2015
Q2 		$138K Buy
10,879
+244
+2% +$2.77K ﹤0.01% 2865
2015
Q1 		$126K Buy
+10,635
New +$122K ﹤0.01% 2842
2014
Q4 		– Sell
-205,330
Closed -$1.91M – 3021
2014
Q3 		$1.91M Sell
205,330
-4,280
-2% -$32.8K ﹤0.01% 1790
2014
Q2 		$1.37M Sell
209,610
-20,029
-9% -$132K ﹤0.01% 2087
2014
Q1 		$1.85M Buy
229,639
+3,937
+2% +$38.7K 0.01% 1850
2013
Q4 		$2.25M Buy
225,702
+102,010
+82% +$707K 0.01% 1678
2013
Q3 		$750K Buy
123,692
+11,217
+10% +$64.3K ﹤0.01% 2240
2013
Q2 		$580K Buy
+112,475
New +$576K ﹤0.01% 2363

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Guggenheim Capital's CCRN Position: Q4 2025 in Review

Guggenheim Capital sold out of Cross Country Healthcare (CCRN) in Q4 2025, closing a stake of 18,146 shares — an estimated $258K sold.

Guggenheim Capital first reported a position in CCRN in Q2 2013 and held it in 35 quarters. The position peaked at $3.56M in Q4 2015. 147 funds tracked by Wall St. Rank hold CCRN as of Q4 2025.

  • Guggenheim Capital reported no remaining Cross Country Healthcare position as of Q4 2025 after selling out during the quarter.
  • Guggenheim Capital sold 18,146 Cross Country Healthcare shares in Q4 2025, an estimated $258K.
  • Guggenheim Capital first reported a position in Cross Country Healthcare in Q2 2013 and held it in 35 quarters.
  • Guggenheim Capital's Cross Country Healthcare position peaked at $3.56M in Q4 2015.
  • 147 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2025.

Based on Guggenheim Capital's 13F filing for Q4 2025, filed 17 Feb 2026.